Biotech news today
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Software M MetaphysicalCells
Friday's Latest TechBio News 🟣đźź
More News from Proscia, South Korea, Taiwan, Hong Kong, India, and many more
Software L Latch Bio
Open Source Classifiers Do Not Stop AI Bioweapon Generation
A few days ago Mistral released Shieldstral, its new safety classifier, without disclosing its performance on major biosecurity related tasks, such as viral engineering.
Software
Decoding Bio
BioByte 167: Prediction of Ligand-Residue Interactions with Ptarmigan-1, Improvements in the Physiological Relevance of DepMap, and Resetting the Growth Trajectory of Developing Organs After Injury
Welcome to Decoding Bio’s BioByte: each week our writing collective highlight notable news—from the latest scientific papers to the latest funding rounds—and everything in between.
Research
C&EN Pharmaceuticals
This new human genome has almost no gaps
Researchers have assembled the first telomere-to-telomere, diploid phased genome from a single human cell line
Agriculture E European Seed
Xylella Research Advances Disease Control
Research on Xylella fastidiosa is advancing resistant olive cultivars, biological control, insect vector management and surveillance. Findings presented in Italy could support improved disease management and olive production recovery in affected regions. The post Xylella Research…
Software M Molecular Design
Variability in biological activity measurements reported in the drug discovery literature
I'll open the post with a panorama from the summit of Shutlingsloe, sometimes referred to as Cheshire's Matterhorn, which at 506 m above sea level, is the third highest point in the county. When in the UK, I usually come here to mark the solstices and there's usually a good crowd…
Software P Pistoia Alliance
The global landscape and regulations continue to evolve. Are you ready?
The rulebook on controlled substances keeps widening, and the supply chain keeps shifting. The success of teams responsible for compliance and shipping lies in exchange and prevention. The post The global landscape and regulations continue to evolve. â€¦
Industry P Patent Docs
Moderna Appeals District Court Infringement Judgment over COVID Vaccines
By Kevin E. Noonan – One of the beneficial characteristics of the response to the COVID-19 pandemic were pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech, and others) not to enforce patents on relevant technology during the duration. …
Industry P Patent Docs
Arbutus Responds to Moderna’s Appeal of District Court Infringement Judgment over COVID Vaccines
By Kevin E. Noonan – Arbutus Biopharma and Genevant Sciences, having prevailed in district court litigation against Moderna involving infringement of U.S. Patent Nos. 8,058,069, 8,492,359, 8,822,668, 9,364,435, 9,504,651, and 11,141,378 regarding lipid nanoparticle (LNP) technolo…
Industry I In the Pipeline
Put Your Money Down, They Say
Most people probably don’t realize it, but the prediction/betting market like Kalshi and Polymarket have begun taking bets on things like the success of Phase III drug trials. The New York Times highlighted this recently, and I wanted to weigh in on this idea. Not least because i…
Software S Scaling Biotech
Does biopharma data need a Maslow Hierarchy?
The risks that I see most often in Data Risk Reviews seem to fall into three main categories that form a kind of Maslow-style hierarchy.
Agriculture T The Labs Report
Tiny and Mighty: One of Biology’s Smallest Systems with Outsized Potential in Agriculture
Inspired by viroids and Flagship Labs’ long history pioneering RNA therapeutics, engineered RNAs deliver targeted crop-protection instructions without editing the plant genome.
Agriculture E European Seed
Global Soil Degradation Is Cutting Crop Yields
University of Bonn researchers found that soil degradation is significantly reducing crop yields worldwide. Reversing human-caused degradation could increase production enough to feed approximately 70 million more people. The post Global Soil Degradation Is Cutting Crop Yields ap…
Industry I In the Pipeline
Target Practice on the Molecular Scale
I’ve remarked before that one of the big differences in the modern chemical literature versus the “back when I was in grad school” era (which for me is the 1980s, dang it all) is that we now can do a lot more at smaller scales. Detailed pictures of surface and single-molecule phe…
Funding
C&EN Pharmaceuticals
Business Watch: War doesn’t stop Gulf chemical makers; BMS and AstraZeneca reportedly in merger talks
Here’s what we’re watching in the chemical and pharmaceutical industries this week
Industry
C&EN Pharmaceuticals
Chemistry in Pictures: Droplet with a steering wheel
Software
Ground Truths
Sarah Urbut: Predicting Your Health Arc
Watch now (54 mins) | Sarah Urbut MD, PhD Takes Us Through Her Landmark Nature Paper
Agriculture E European Seed
New Gene Insertion Method Could Support Crop Traits
KAUST researchers have developed a gene insertion method that precisely adds large genetic sequences into plant genomes without first breaking DNA. The technique, demonstrated in rice and tobacco, could support more complex crop traits and plant-based biomanufacturing. The post N…
Software O Open Targets
Origins of the IBDverse: how a conversation in a carpark became one of the largest gut cell studies
In 2015, Tim Raine and Carl Anderson had the ambitious idea of using single-cell sequencing to gain insights into the genes and cell types causally driving Inflammatory Bowel Disease (IBD), a project christened the “IBDverse”. They explain the gambles they took on the project, an…
Software P Pistoia Alliance
The Blind Spots of Explainable AIÂ
Once anyone can spin up an AI agent, the challenge isn't explaining how AI decides, it's designing what role it plays. Stijn Janssen proposes a new discipline: Actor Experience. The post The Blind Spots of Explainable AI appeared first on Pistoia Alliance.
Industry W What do you mean heterogeneity?
Tissue homing and gene expression
I was thinking about my reading habits.
Industry I In the Pipeline
We Only Know Her as Mei
If you haven’t read this story yet, you should. It’s an excellent piece of journalism from the team here at Science and at Retraction Watch, and it reveals a previously unreported death from an attempt at gene therapy in China last year. We know where it happened (Xinhua Hospital…
Software T This Week in Cheminformatics
This Week In Cheminformatics: Issue #032
Domain adaptation for Transformers, MPO guided by Bioisostere replacement, Boltz‑2 Evaluation, and a long list of papers
Funding
Pharmaceutical Processing World
Codis completes acquisition of Catalent manufacturing plant
Codis announced today that it completed its previously announced acquisition of a UK-based manufacturing facility from Catalent. The Haverhill, England-based company agreed to acquire the oral solid dose (OSD) development and manufacturing plant in Nottingham last month. The faci…
Software B Biocene
The Sirens of Data Sales
Why selling data to train models is not as easy a decision as you think for bio companies
Industry P Practical Fragments
Merck’s journey from flatland
Back in 2009 we highlighted a paper, “Escape from flatland,” suggesting that molecules with higher fractions of sp3-hybridized (ie, non-aromatic) carbons are more likely to become drugs. This hypothesis has been challenged on methodological grounds, and an analysis last year conc…
Software M Matt Gamber
Q2 2026 Earnings Preview: What I'm Watching
TGTX, GERN, HROW, CGEM, ABVX, CELC, DCTH, TARS, EWTX, IDYA, XERS, EOLS, MNKD, VIR.
Agriculture E European Seed
Climate Change Threatens Crop Nutrition
Climate change is reducing the nutritional value of major food crops, creating new challenges for food security. A Nature review examines how plant breeding, genome editing and other technologies could improve crop nutrition while strengthening climate resilience. The post Climat…
Software O Omics! Omics!
When PCR Gives You Lemons...
I wish to highlight an interesting new preprint from a group at Danish Technical University which explores the schmutz in PCR reactions, demonstrates some surprising conclusions, shows how their results might be very relevant to a common use of amplicon sequencing, and demonstrat…
Industry I In the Pipeline
The Gut Microbiome and Cancer Therapy
Here’s some work that ties in with that post I did the other day about bacterial associations with cancer (or the general lack of same). It’s been known for some time that cancer immunotherapy responses are influenced by the human microbiome - for example, antibiotic treatment se…
Industry
Pharmaceutical Processing World
Advancing Pressure Protection in Biopharma: How Integrated Bypass Technology Elevates Single-Use Pump Design
by Michael Irving, Xylem In pharmaceutical and biopharmaceutical manufacturing, there is zero margin for error when it comes to process integrity and operator safety. Among the many variables that must be tightly controlled, pressure ranks high on the list. Overpressure or vacuum…
Software I Is life worth living?
Run Openfold3 on my laptop machine #openfold3 #co-folding #informatics
Recently several co-folding AI are available, for example AF3, Chai-1, protenix and openfold. This area is hot and growing day by day. Co-Folding AI has potential for taking SBDD approach without determining the target protein-ligand structure. As most of readers know that there…
Funding
Pharmaceutical Processing World
Ratio Therapeutics raises $70M to expand manufacturing infrastructure
Ratio Therapeutics announced today that it closed a $70 million Series C financing to support its radiopharmaceutical development and manufacturing. Existing investors Duquesne Family Office and Bristol Myers Squibb participated. New investors Catalio Capital Management, Eli Lill…
Industry
C&EN Pharmaceuticals
Editorial: Gene therapies are too special to treat like other drugs
A recent tragedy in China reminds us of important lessons for managing drug trials of gene therapies
Industry I In the Pipeline
A Friendlier Fluorination
Let’s do some good ol’ organic synthesis today. Probably not so many of the chemists in the audience will have run the good ol’ Appel reaction (alcohol to alkyl chloride with triphenylphosphine and carbon tetrachloride), because good ol’ carbon tet has been disappearing from the…
Software P Pistoia Alliance
UX in Life Sciences: What’s Actually Different — and Why It Matters
In life sciences, the product isn't the software, it's the therapy. This opening UXLS article explores why that makes UX fundamentally different and strategic. The post UX in Life Sciences: What’s Actually Different — and Why It Matters appeared first on Pistoia Alliance.